Safety of elevated pulmonary doses from [177Lu]Lu-PSMA-617 and 90Y-radioembolization therapies

被引：0
|
作者：
Jain, S. [1 ]
Graves, S. A. [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-1229
引用
收藏
页码：S919 / S919
页数：1
相关论文
共 50 条
  • [1] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    Maarten de Bakker
    Noa Dominicus
    Antoi Meeuwis
    Marcel Janssen
    Mark W. Konijnenberg
    James Nagarajah
    Steffie M. B. Peters
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3572 - 3575
  • [2] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    de Bakker, Maarten
    Dominicus, Noa
    Meeuwis, Antoi
    Janssen, Marcel
    Konijnenberg, Mark W. W.
    Nagarajah, James
    Peters, Steffie M. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3572 - 3575
  • [3] Clinical dosimetry study of kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T
    Uijen, M.
    Prive, B.
    van Herpen, C.
    Gotthardt, M.
    Konijnenberg, M.
    Peters, S.
    Nagarajah, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S111 - S112
  • [4] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [5] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [6] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Anna Yordanova
    Paula Linden
    Stefan Hauser
    Michael Meisenheimer
    Stefan Kürpig
    Georg Feldmann
    Florian C. Gaertner
    Markus Essler
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1073 - 1080
  • [7] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Yordanova, Anna
    Linden, Paula
    Hauser, Stefan
    Meisenheimer, Michael
    Kuerpig, Stefan
    Feldmann, Georg
    Gaertner, Florian C.
    Essler, Markus
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1073 - 1080
  • [8] Kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry
    Uijen, Maike J. M.
    Prive, Bastiaan M.
    van Herpen, Carla M. L.
    Westdorp, Harm
    van Gemert, Willemijn A.
    de Bakker, Maarten
    Gotthardt, Martin
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    Nagarajah, James
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (04) : 270 - 275
  • [9] [177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease
    Mercolli, Lorenzo
    Mingels, Clemens
    Manzini, Giulia
    Cumming, Paul
    Zeimpekis, Konstantinos
    Xue, Song
    Alberts, Ian
    Uehlinger, Dominik
    Rominger, Axel
    Shi, Kuangyu
    Afshar-Oromieh, Ali
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (10) : 1570 - 1573
  • [10] AUTOMATED RADIOSYNTHESIS OF [177LU]LU-PSMA-617 ON THE IPHASE MULTISYN MODULE
    Wichmann, C.
    Ackermann, U.
    Poniger, Stan
    Young, K.
    Chan, G.
    Hofman, M.
    Lee, S. T.
    Sachinidis, J.
    Scott, A.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 31 - 32
12345